Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Fusion Pharmaceuticals Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 38 | 39 | +1 |
| Shares | 27.6M | 27.5M | −119.1K (−0.4%) |
| Value | $295.9M | $221.8M | −$74.1M (−25.0%) |
New holders (5)
Institutions that held Fusion Pharmaceuticals Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 14,180 | $114.0K | 0.00% |
| UBS Group AG | 3,825 | $31.0K | 0.00% |
| Bank Julius Baer & Co. Ltd, Zurich | 1,980 | $16.0K | 0.00% |
| Simplex Trading, LLC | 1,308 | $10.0K | 0.00% |
| Paragon Wealth Strategies, LLC | 18 | $0 | 0.00% |
Sold out (4)
Institutions that held Fusion Pharmaceuticals Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Vanguard Group Inc | 36,394 | $390.0K |
| Susquehanna Fundamental Investments, LLC | 25,168 | $270.0K |
| Millennium Management LLC | 10,726 | $115.0K |
| Susquehanna International Group, LLP | 10,745 | $115.0K |